Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Spikevax“
Suchtreffer
Begriffe & Kennungen
Spikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 61 Description of selected adverse reactions
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 7 A Phase 2/3 randomised, placebo-controlled, observer-blind study to evaluate the safety, tolerability, react
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 8 MedDRA system organ class Frequency Adverse reactions Not known Hypersensitivity
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · 9 Adults (booster dose) The safety, reactogenicity, and immunogenicity of a booster dose of Spikevax (original
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Adolescents 12 through 17 years of age Safety data for Spikevax (original) in adolescents were collected in a
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Adolescents 12 through 17 years of age Safety data for Spikevax (original) in adolescents were collected in a
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Adolescents 12 through 17 years of age Safety data for Spikevax (original) in adolescents were collected in a
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Adverse reactions reported are listed according to the following frequency convention:
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Adverse reactions reported are listed according to the following frequency convention:
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Adverse reactions reported are listed according to the following frequency convention:
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Children 6 months through 5 years of age
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Children 6 months through 5 years of age
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Children 6 months through 5 years of age
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Children 6 years through 11 years of age Safety data for Spikevax (original) in children were collected in a P
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Children 6 years through 11 years of age Safety data for Spikevax (original) in children were collected in a P
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · Children 6 years through 11 years of age Safety data for Spikevax (original) in children were collected in a P
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · In Part A, 128 SOT recipients received a third dose of Spikevax (original). In Part B, 159 SOT recipients rece
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · In Part A, 128 SOT recipients received a third dose of Spikevax (original). In Part B, 159 SOT recipients rece
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · In Part A, 128 SOT recipients received a third dose of Spikevax (original). In Part B, 159 SOT recipients rece
Eintrag öffnenSpikevax (previously COVID-19 Vaccine Moderna) · 4.8 · In this clinical study, the adverse reactions in participants 6 months through 23 months of age following admi
Eintrag öffnen